Development of Acute Metabolic Acidosis in a Pediatric Patient with Idiopathic Intracranial Hypertension Treated with Acetazolamide: A Case Report

Mitchell Strohmaier, Regan A Baum, Abby M Bailey and Jonathan Bronner

Department of Emergency Medicine, St. Elizabeth Healthcare, USA
Department of Emergency Medicine, University of Kentucky Health Care, USA

^*Correspondance to: Regan A Baum 

 PDF  Full Text Case Report | Open Access

Abstract:

Background: Idiopathic intracranial hypertension (IIH) treatment consists of both lifestyle modification and medical/surgical therapy. Acetazolamide, a carbonic anhydrase inhibitor, is the primary medical treatment with adverse effects including neurologic symptoms and the development of metabolic acidosis.Case
Presentation: We present a case report of a pediatric patient (with pre-diabetes treated with metformin) who acutely developed metabolic acidosis and paresthesias following treatment with acetazolamide for IIH diagnosis.Conclusion: Special awareness by the clinician must be undertaken when acetazolamide is initiated in the presence of current treatment with additional medications that could contribute to the furthering of metabolic acidosis.

Keywords:

Metabolic acidosis; Acetazolamide; Idiopathic intracranial hypertension; Metformin

Cite the Article:

Strohmaier M, Baum RA, Bailey AM, Bronner J. Development of Acute Metabolic Acidosis in a Pediatric Patient with Idiopathic Intracranial Hypertension Treated with Acetazolamide: A Case Report. Ann Clin Case Rep. 2018; 3: 1530.